ProMIS Neurosciences Inc. (PMN)

NASDAQ

$8.30

$-0.10

(-1.19%)

Regular Market

ProMIS Neurosciences Inc. (PMN) Live Price Chart

Last updated: ⁦2026-10-21 15:01:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

ProMIS Neurosciences Inc. (PMN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.30, with a market capitalization of $73.80M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.27 to $27.40. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$73.80M
Open	$8.40
Day's High	$350.00
Day's Low	$6.27
Previous Close	$8.09
Volume	2.00K
Average Volume	68.56K
P/E Ratio	--
52-Week High	$27.40
52-Week Low	$6.27
Dividend Yield	--
Earnings Date	--

ProMIS Neurosciences Inc. (PMN) Stock Price Today

ProMIS Neurosciences Inc. (PMN) is currently trading at $8.30 as of 2026-10-21 14:59:00, up 2.60% ($0.21) from the previous close of $8.09

During today's regular trading session, PMN has traded between $6.27 and $350.00, with a trading volume of 2.00K shares. The current price is near the lower end of today's range.

ProMIS Neurosciences Inc. (PMN) 7-Day Stock Price Change

Over the past seven days, ProMIS Neurosciences Inc. (PMN) moved from $9.45 to $8.30, representing a decline of 12.17% ($1.15).

The stock traded between $7.85 and $9.78 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 24.26 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PMN 52-Week Price Position

Position in Range: 9.6%

52W Low$6.27

52W High$27.40

PMN is currently trading at $8.30, placing it 9.6% of the way from its 52-week low of $6.27 to its 52-week high of $27.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ProMIS Neurosciences Inc. (PMN)?

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

ProMIS Neurosciences Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	11
Exchange	NASDAQ
Company Website	https://www.promisneurosciences.com

How to Buy ProMIS Neurosciences Inc. (PMN) Stock on MEXC

Eligible investors can buy real shares of ProMIS Neurosciences Inc. (PMN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PMN and Place Your Order

Open the RealStocks trading page and search for PMN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ProMIS Neurosciences Inc. (PMN) stock price today?

ProMIS Neurosciences Inc. (PMN) is currently trading at $ 8.30, up 2.60% ($0.21) from the previous close of $ 8.09. Intraday prices update in real time during regular trading hours.

2.Is PMN stock going up or down today?

As of 2026-10-21 14:59:00, PMN is trading at $ 8.30, up 2.60% ($0.21) from its previous close of $ 8.09. The stock has traded between $ 6.27 and $ 350.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is PMN pre-market price?

As of 2026-10-21 14:59:00, PMN is trading at $ 8.09 in pre-market trading, unchanged from the previous close of $ 8.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PMN after-hours price?

As of 2026-10-21 14:59:00, PMN is trading at $ 7.80 in after-hours trading, down 3.58% ($0.29) from the regular-session close of $ 8.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PMN stock trading now?

PMN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PMN sit relative to its 52-week high and low?

Over the past 52 weeks, PMN has traded between a low of $ 6.27 and a high of $ 27.40. At $ 8.30, the stock is positioned 9.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ProMIS Neurosciences Inc. in?

ProMIS Neurosciences Inc. (PMN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ProMIS Neurosciences Inc.'s market capitalization and where is it listed?

ProMIS Neurosciences Inc. is listed on the NASDAQ exchange with a market capitalization of $ 73.80M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PMN valued in terms of P/E ratio and EPS?

PMN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.71. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ProMIS Neurosciences Inc. pay a dividend?

ProMIS Neurosciences Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.